Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tatjana Schwarz and Victor Corman.
Tatjana Schwarz
Connection Strength
2.173
Victor Corman
  1. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol. 2021; 12:629185.
    View in: PubMed
    Score: 0.936
  2. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
    View in: PubMed
    Score: 0.237
  3. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis. 2021 08; 27(8):2169-2173.
    View in: PubMed
    Score: 0.237
  4. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
    View in: PubMed
    Score: 0.061
  5. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
    View in: PubMed
    Score: 0.060
  6. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology. Front Immunol. 2021; 12:687449.
    View in: PubMed
    Score: 0.060
  7. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis. Front Immunol. 2021; 12:690698.
    View in: PubMed
    Score: 0.060
  8. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.059
  9. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors. J Immunol. 2021 06 01; 206(11):2614-2622.
    View in: PubMed
    Score: 0.059
  10. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies. Transfus Med Hemother. 2021 May; 48(3):137-147.
    View in: PubMed
    Score: 0.059
  11. Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing. J Infect Dis. 2021 03 03; 223(5):796-801.
    View in: PubMed
    Score: 0.058
  12. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2020; 11:628971.
    View in: PubMed
    Score: 0.058
  13. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients. Front Immunol. 2020; 11:607918.
    View in: PubMed
    Score: 0.058
  14. Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma. J Virol Methods. 2021 02; 288:114031.
    View in: PubMed
    Score: 0.057
  15. Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center. J Clin Med. 2020 Oct 23; 9(11).
    View in: PubMed
    Score: 0.057
  16. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020 11 12; 183(4):1058-1069.e19.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.